These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23714139)

  • 1. Inductively coupled plasma mass-spectrometric determination of platinum in excretion products of client-owned pet dogs.
    Janssens T; Brouwers EE; de Vos JP; de Vries N; Schellens JH; Beijnen JH
    Vet Comp Oncol; 2015 Jun; 13(2):124-32. PubMed ID: 23714139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of platinum originating from carboplatin in human urine and canine excretion products by inductively coupled plasma mass spectrometry.
    Janssens T; Brouwers EE; de Vos JP; Schellens JH; Beijnen JH
    J Anal Toxicol; 2011 Apr; 35(3):153-61. PubMed ID: 21439151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of platinum originating from carboplatin in canine sebum and cerumen by inductively coupled plasma mass spectrometry.
    Janssens T; Brouwers EE; de Vos JP; Schellens JH; Beijnen JH
    J Pharm Biomed Anal; 2011 Jan; 54(2):395-400. PubMed ID: 20933356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical trial of oral rosiglitazone in combination with intravenous carboplatin in cancer-bearing dogs.
    Allstadt Frazier S; McKemie DS; Guerrero TA; LaChapelle H; Skorupski KA; Kass PH; Rodriguez CO
    Vet Comp Oncol; 2014 Mar; 12(1):1-9. PubMed ID: 22364238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of carboplatin pharmacokinetics in pediatric oncology by means of inductively coupled plasma mass spectrometry.
    Clerico A; Cappelli C; Ragni G; Caroli S; De Ioris MA; Sordi A; Petrucci F; Bocca B; Alimonti A
    Ann Ist Super Sanita; 2006; 42(4):461-8. PubMed ID: 17361071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of platinum surface contamination in veterinary and human oncology centres using inductively coupled plasma mass spectrometry.
    Janssens T; Brouwers EE; de Vos JP; de Vries N; Schellens JH; Beijnen JH
    Vet Comp Oncol; 2015 Sep; 13(3):305-13. PubMed ID: 24034226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin.
    Fox LE
    J Am Anim Hosp Assoc; 2000; 36(1):13-4. PubMed ID: 10667400
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of pelvic transarterial chemoembolization with lipiodol ultra-fluid carboplatin and transarterial carboplatin through experiment in dogs].
    Chen CL; Sun MH; Tan DC; Liang LZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1405-8. PubMed ID: 15566645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation on pharmacokinetics, tissue distribution and excretion of a novel platinum anticancer agent in rats by inductively coupled plasma mass spectrometry (ICP-MS).
    Zhao J; Wen Y; Zhang W; Zhao D; Fan A; Zhang Y; Deng S; Wang X; Liu Q; Lu Y; Wang Z; Gou S; Chen X
    Xenobiotica; 2014 Aug; 44(8):757-62. PubMed ID: 24524624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of platinum content in biodegradable carboplatin-impregnated beads and retrospective assessment of tolerability for intralesional use of the beads in dogs following excision of subcutaneous sarcomas: 29 cases (2011-2014).
    Hess TA; Drinkhouse ME; Prey JD; Miller JM; Fettig AA; Carberry CA; Brenn SH; Bailey DB
    J Am Vet Med Assoc; 2018 Feb; 252(4):448-456. PubMed ID: 29393745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an extractionless high-performance liquid chromatography-tandem mass spectrometry method for detection and quantitation of rosiglitazone in canine plasma.
    Frazier SA; McKemie DS; Guerrero TA; Skorupski KA; Rodriguez CO
    Am J Vet Res; 2011 Feb; 72(2):263-70. PubMed ID: 21281203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of platinum, arsenic and selenium of cancer patients from the Antofagasta region in Chile treated with platinum-based drugs.
    Román DA; Pizarro I; Rivera L; Torres C; Avila J; Cortés P; Gill M
    BMC Res Notes; 2012 Apr; 5():207. PubMed ID: 22546077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Owner's perception of carboplatin in conjunction with other palliative treatments for cancer therapy.
    Bowles DB; Robson MC; Galloway PE; Walker L
    J Small Anim Pract; 2010 Feb; 51(2):104-12. PubMed ID: 20070498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring carboplatin concentrations in saliva: a replacement for plasma ultrafiltrate measurements?
    van Warmerdam LJ; van Tellingen O; ten Bokkel Huinink WW; Rodenhuis S; Maes RA; Bijnen JH
    Ther Drug Monit; 1995 Oct; 17(5):465-70. PubMed ID: 8585109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
    de Vos J; Ramos Vega S; Noorman E; de Vos P
    Vet Comp Oncol; 2012 Sep; 10(3):206-13. PubMed ID: 22236048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas.
    Menard K; Flesner BK; Glahn A; Boudreaux B; Bryan JN
    Vet Comp Oncol; 2018 Dec; 16(4):590-595. PubMed ID: 30043425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic drug residues in urine of dogs receiving anticancer chemotherapy.
    Knobloch A; Mohring SA; Eberle N; Nolte I; Hamscher G; Simon D
    J Vet Intern Med; 2010; 24(2):384-90. PubMed ID: 20102496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
    Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
    J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006-2010).
    Simcock JO; Withers SS; Prpich CY; Kuntz CA; Rutland BE
    J Am Vet Med Assoc; 2012 Sep; 241(5):608-14. PubMed ID: 22916858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.